Live Breaking News & Updates on Kitov Pharmaceuticals

Stay updated with breaking news from Kitov pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Osteoarthritis Therapeutics Market worth $11.0 billion by 2025 - Exclusive Report by MarketsandMarkets™


The growth of this market is driven by significant adoption of pain medications, increasing prevalence of osteoarthritis, growing population susceptible to osteoarthritis, and rising number of sports injuries.
Knee osteoarthritis therapeutics is expected to hold the largest share of the osteoarthritis therapeutics market, by anatomy in 2020.
Based on anatomy, the market is segmented into knee, hip, hand, and small-joint osteoarthritis therapeutics. Knee osteoarthritis therapeutics is the largest and the fastest-growing segment in this market. This can primarily be attributed to the high incidence of knee osteoarthritis.
Viscosupplementation agents is expected to hold the largest share of the market, in 2020.
Based on drug type, the market is classified as, viscosupplementation agents, nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids. The analgesics segment is subsegmented into duloxetine and acetaminophen, while the NSAIDs segment ....

United States , United Kingdom , Laboratorio Reig Jofre , Asia Pacific , Aashish Mehra , Fidia Farmaceutici , Almatica Pharma , Pfizer Inc , Pharmaceuticals Market Research Reports Consulting , Zimmer Biomet Holdings Inc , Co Ltd , Pharmed Limited India , Orthopedic Software Market , Ferring Pharmaceuticals Switzerland , Route Of Administration Parenteral , Assertio Therapeutics Inc , Research Insight , Flexion Therapeutics Inc , Kitov Pharmaceuticals Ltd , Anika Therapeutics Inc , Horizon Therapeutics , Therapeutics Market , Drug Type , Distribution Channel , Hospital Pharmacies , Purchasing Pattern ,